Press Release 2015

Press Release 2015

Sabinsa Corporation is pleased to announce the availability of Curry Powder to Clinical Significance, by NutriScience Publishers, LLC 1st Edition. This comprehensive hard-cover book captures the robust body of science on Curcumin in the clinical setting, and goes on to cover the history of Sabinsa’s Curcumin C3 Complex®.

Curry Powder to Clinical Significance delvers into curcumin chemistry, and the many health benefits Curcumin provides which have been verified by numerous human clinical studies. It gives an overview of clinical studies on C3 Complex for a variety of medical conditions ranging from Cardiovascular to Radiation Dermatitis.

Edited by Sabinsa founder Muhammed Majeed Ph.D., and Anju Majeed MS, the book is dedicated to India’s 11th President Dr. APJ Abdul Kalam, a scientist, who visited Sami/Sabinsa shortly before he passed away.

Curcumin C3 Complex® is the subject of more clinical studies than any other branded curcumin in the world. Sami-Sabinsa has been conducting research on Curcumin for 26 years, and has been deeply involved in taking scientific knowledge of this popular herb from experience-based accounts to evidence-based claims, driven by a vigorous body of research.

The book is currently available on Amazon (USA): http://bit.ly/cp2csbook. 

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.